Simulect Related Clinical Trials
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant [Terminated]
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) [Completed]
Simulect Versus ATG in Sensitized Renal Transplant Patient [Recruiting]
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease [Recruiting]
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids [Completed]
Basiliximab in Moderate to Severe Ulcerative Colitis [Completed]
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids [Completed]
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation [Recruiting]
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer [Completed]
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis [Terminated]
Basiliximab Maintenance in Ulcerative Colitis [Terminated]
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major [Recruiting]
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. [Completed]
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment [Recruiting]
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients [Completed]
Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma [Recruiting]
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations [Terminated]
The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea [Recruiting]
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients [Completed]
Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant [Completed]
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation [Completed]
ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF [Recruiting]
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia [Recruiting]
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma [Recruiting]
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission [Active, not recruiting]
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients [Completed]
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids [Completed]
Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation [Completed]
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation [Completed]
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation [Recruiting]
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients [Completed]
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy [Active, not recruiting]
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. [Completed]
Safety and Efficacy of a Steroid-free, Calcineurin Inhibitor-free, Belatacept-based Immunosuppressive Regimen [Active, not recruiting]
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery [Completed]
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients [Active, not recruiting]
Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients [Completed]
Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation [Recruiting]
Steroid Free Immunosuppression in Liver Transplantation [Completed]
Thymoglobulin Induction in Kidney Transplant Recipients [Not yet recruiting]
Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy [Completed]
Thymus Transplantation Safety-Efficacy [Recruiting]
Stem Cell Transplantation for Patients With Multiple Myeloma [Active, not recruiting]
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [Completed]
Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation [Recruiting]
Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients [Completed]
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) [Completed]
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids [Completed]
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program [Terminated]
LEA29Y (Belatacept) Emory Edmonton Protocol [Completed]
EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function [Not yet recruiting]
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients [Completed]
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) [Active, not recruiting]
Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients [Completed]
Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients [Completed]
Effect of SVF Derived MSC in DCD Renal Transplantation [Recruiting]
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients [Completed]
Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab [Completed]
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients [Completed]
Induction With SVF Derived MSC in Living-related Kidney Transplantation [Recruiting]
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids [Completed]
Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients [Recruiting]
Multi-peptide Vaccine With Basilixumab for Breast Cancer [Recruiting]
Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients [Recruiting]
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts [Active, not recruiting]
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection [Completed]
Steroid Withdrawal in Pediatric Kidney Transplant Recipients [Terminated]
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant [Withdrawn]
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation [Completed]
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Active, not recruiting]
CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment [Completed]
Induction Related BK Viremia in Renal Transplant Patients [Completed]
MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive [Terminated]
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol [Recruiting]
Steroid Withdrawal Immunosuppression After Renal Transplantation [Recruiting]
Belatacept in Liver Transplant Recipients [Terminated]
Optimization of NULOJIX® (Belatacept) Usage As A Means of Avoiding Calcineurin Inhibitor (CNI) and Steroids in Renal Transplantation [Suspended]
Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation [Recruiting]
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant [Not yet recruiting]
Islet Transplantation in Type 1 Diabetes [Completed]
Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients [Completed]
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure [No longer available]
In-Vivo Activated T-Cell Depletion to Prevent GVHD [Terminated]
Efficacy of Islet After Kidney Transplantation [Active, not recruiting]
Kidney Graft Function Under the Immunosuppression Strategies [Completed]
A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation [Withdrawn]
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists [Active, not recruiting]
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients [Completed]
Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS [Completed]
Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center [Not yet recruiting]
Freedom Study: Myfortic in Kidney Transplant Patients [Completed]
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf [Recruiting]
ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION [Completed]
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Completed]
Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction [Recruiting]
Strategies to Improve Islet Survival [Completed]
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Completed]
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients [Completed]
|